pCMV-hAR Citations (4)

Originally described in: Cloning of human androgen receptor complementary DNA and localization to the X chromosome.
Lubahn DB, Joseph DR, Sullivan PM, Willard HF, French FS, Wilson EM Science. 1988 Apr 15;240(4850):327-30. PubMed

---

Articles Citing pCMV-hAR

Articles
Epistane, an anabolic steroid used for recreational purposes, causes cholestasis with elevated levels of cholic acid conjugates, by upregulating bile acid synthesis (CYP8B1) and cross-talking with nuclear receptors in human hepatocytes. Petrov PD, Fernandez-Murga L, Conde I, Martinez-Sena T, Guzman C, Castell JV, Jover R. Arch Toxicol. 2020 Jan 1. pii: 10.1007/s00204-019-02643-y. doi: 10.1007/s00204-019-02643-y. PubMed
Discovery of a novel nonsteroidal selective glucocorticoid receptor modulator by virtual screening and bioassays. Pang JP, Hu XP, Wang YX, Liao JN, Chai X, Wang XW, Shen C, Wang JJ, Zhang LL, Wang XY, Zhu F, Weng QJ, Xu L, Hou TJ, Li D. Acta Pharmacol Sin. 2022 Sep;43(9):2429-2438. doi: 10.1038/s41401-021-00855-6. Epub 2022 Feb 2. PubMed
YAP antagonizes TEAD-mediated AR signaling and prostate cancer growth. Li X, Zhuo S, Cho YS, Liu Y, Yang Y, Zhu J, Jiang J. EMBO J. 2023 Feb 15;42(4):e112184. doi: 10.15252/embj.2022112184. Epub 2023 Jan 2. PubMed
The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer. Constantin TA, Varela-Carver A, Greenland KK, de Almeida GS, Olden E, Penfold L, Ang S, Ormrod A, Leach DA, Lai CF, Ainscow EK, Bahl AK, Carling D, Fuchter MJ, Ali S, Bevan CL. Br J Cancer. 2023 Jun;128(12):2326-2337. doi: 10.1038/s41416-023-02252-8. Epub 2023 Apr 19. PubMed

If you have published an article using this material, please email us at to have your article added to this page.